(NYSE: WST) West Pharmaceutical Services's forecast annual revenue growth rate of 5.68% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.02%.
West Pharmaceutical Services's revenue in 2026 is $3,221,000,000.On average, 19 Wall Street analysts forecast WST's revenue for 2026 to be $237,305,271,605, with the lowest WST revenue forecast at $224,800,647,290, and the highest WST revenue forecast at $252,565,152,125. On average, 19 Wall Street analysts forecast WST's revenue for 2027 to be $251,999,971,365, with the lowest WST revenue forecast at $238,788,871,100, and the highest WST revenue forecast at $270,580,288,850.
In 2028, WST is forecast to generate $269,167,336,950 in revenue, with the lowest revenue forecast at $253,978,104,025 and the highest revenue forecast at $290,644,205,830.